Dr. P Jovita .M .Martin Daniel

Major Cancer Types Treated:

• Breast Cancer
• Gynaecological Cancers
• Genitourinary Malignancies
• Paediatric Malignancies
• Lung Cancer
• Gastrointestinal Cancers
• Head & Neck Cancers
• Lymphomas
• Leukemia
• Bone Cancer
• Soft Tissue Sarcomas
• Thyroid Cancer

Sub-specialties:

• Medical Oncology
• Radiation Oncology
• Palliative Care
• Precision Oncology
• Preventive Oncology
• Geriatric Oncology
• Genetics in Cancer
• Targeted Therapy
• Immuno-Oncology

Advanced Procedures Performed:

• • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Transarterial Chemoembolization (TACE)
  • Breast Conservation Surgery (BCS)
  • Breast Lumpectomy
  • IMRT (Intensity-Modulated Radiation Therapy)
  • HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
  • Parathyroidectomy
  • Lobectomy
  • Completion Thyroidectomy
  • Breast Biopsy
  • Paediatric Bone Marrow Transplant

• Current & Past Hospital Affiliations:

Current Affiliations:

• Senior Consultant, MGM Cancer Institute, Chennai
• Visiting Professor, Sri Balaji Vidyapeeth University, Puducherry, India

Past Affiliations:

• Associate Professor, Sri Ramachandra Institute Of Higher Education and Research, Porur (April 2019 - May 2023)
• Assistant Professor, Sri Ramachandra Institute Of Higher Education and Research, India (November 2017 - March 2019)
• Radiation Oncologist - Visiting Consultant, Dr. Rai Memorial Medical Centre, Chennai Area, India (June 2008 - May 2023)
• Junior Consultant/Assistant Professor, Tamilnadu Government Multi Super Speciality Hospital, Chennai Area, India (October 2015 - November 2017)
• Radiation Oncologist - Visiting Consultant, Dr. Kamachi Memorial Cancer Center, Chennai Area, India (June 2008 - December 2016)
• Radiation Oncologist - Visiting Consultant, Apollo Speciality Cancer Center, Chennai Area, India (June 2008 - December 2012)
• Assistant Professor - Radiation and Clinical Oncology, Sri Ramachandra Medical Center, Chennai Area, India (May 2008 - August 2012)
• Registrar in Medical and Radiation Oncology, VS Hospital, Chennai Area, India (June 2007 - February 2008)

Academic & Research Roles:

• Overseeing academic development of postgraduate programmes.
• Liaisoning with leading pharmaceutical oncology companies for clinical trials and research.
• Coordinating with international forums/associations (ASTRO, ESMO, ASCO, ESTRO) for India-specific initiatives (examinations, exchange programmes, case-based discussions, seminars, CMEs).
• Working with Governmental/NGOs for cancer awareness programmes.

Key Achievements & Contributions:

• • Delivered a guest lecture on “Cancer Awareness” at ASCENDAS, IT Park (2018).
  • Speaker at Best of MASCC, Mumbai, on "Oncological Emergencies in Palliative Care" (2018).
  • Panellist in Multiple Myeloma at Madurai (2018).
  • Speaker at 27th World Oncologists Conference, Chicago, on “A 20 years’ experience on granulosa cell tumour” (2018).

National & International Awards:

• Membership with numerous prestigious national and international medical organisations

Recognitions & Honours:

• Active participation and leadership roles in various medical societies.

Published Papers in Medical Journals:

• Prevalence Of Androgen Receptor Positivity In Triple Negative Breast Cancer, J Integr Oncol (2018)
• A 20 years’ experience on granulosa cell tumour, Journal of Evolution of Medical and Dental sciences (2018)
• Synchronous Malignancy A Rare Presentation of Double Primary in Female Genital Tract, Journal of Evolution Medical and Dental Sciences (2019)
• Drug-related problems and potentially inappropriate medications use in Indian geriatric patients receiving chemotherapy in the medical oncology unit of a tertiary care hospital, Journal of Geriatric Oncology (Year not specified in context)
• A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma, Breast Cancer (Dove Med Press) (2020)
• Cancer Treatment during the Sars-Cov-2 Pandemic: Single Center Analysis, British Journal of Cancer Research (2020)
• Tele Oncology Consultation During the Covid-19 Pandemic: Single Center Analysis, British Journal of Cancer Research (2020)
• Prescribing Pattern of Anticancer Drugs in a Medical Oncology Department of a Tertiary Care Teaching Hospital, Annals of Medical and Health Sciences Research (2017)
• An Uneventful Pregnancy and Delivery in a Metastatic Adult Wilms’ Tumor–A Rare Case Report, MOJ Clinical and Medical Case Reports (2017)
• Multiple Primaries Rising Trend– a Case Series, International Journal of Medical Sciences and Health Research (2017)
• Malignant Invasive Thymoma with chemotherapy alone, Journal of Evolution of Medical and Dental sciences (2017)
• Primary Intraspinal Primitive Neuro ectodermal tumor (PNET): A Rare Occurrence, MOJ Clin Med CASE Rep (2017)
• Malignant Pediatric Gliosarcoma Defies General Survival Data, Case Reports in Medicine (2014)
• An Uneventful pregnancy and delivery, in a case with Chronic Myeloid Leukemia on Imatinib, Journal of Cancer Research and Therapeutics (2011)
• Extranodal Testicular Anaplastic Versus Plasmablastic Plasma Cell Tumor. A Rare Case With Diagnostic Dilemma In A Developing Country, Journal of Cancer Research and Therapeutics (2011)
• Uterine c-kit Positive Sarcoma, Indian Journal of Medical and Pediatric Oncology (2009)
• Prevalence of androgen receptor positivity in triple negative breast cancer, Annals of Oncology (2015)

Ongoing Clinical Trials Participation:

• Principle Investigator: Protocol No: GBR 200-301 “A Prospective, Multicentre, Randomised, Double – blind, Parallel- Group study to compare the efficacy and safety of GBR 200 (similar biologic of trastuzumab) versus innovator trastuzumab both given in combination with paclitaxel in patients diagnosed with HER2 positive Metastatic breast cancer.”
• Principle Investigator: BCD-021-02 “International multicentre randomised double blind phase III trial comparing safety and efficacy of BCD-021 (CJSC BIOCAD, Russia) and paclitaxel + carboplatin to Avastin (F. Hoffmann – La Roche LTD, Switzerland) and paclitaxel + carboplatin in inoperable or advanced non-squamous non-small – cell lung cancer patients.”
• Principle Investigator: A Randomised open labelled two arm, single dose, cross over, bioequivalence study of Ayana pharma Doxorubicin Hydrochloride Liposome injection, Sun pharma in subjects with ovarian cancer.
• Sub-Investigator: A multinational randomised, double blinded, placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy (2008-2010).
• Co-Investigator: A prospective, non-comparative, open labeled, multicenter Post Marketing Safety Surveillance study to evaluate the safety and immunogenicity of neukine in clinical practice (2008-2009).
• Co-Investigator: A phase I/II study to evaluate safety and efficacy of P276-00 in combination with Gemcitabine in patients with cancer of pancreas.
• Co-Investigator: A phase III open label extension trial of the safety and efficacy of ferumoxytol for episodic treatment of Iron deficiency anaemia.
• Co-Investigator: Predictive factors in Stomach Cancers Evaluation of Polymorphisms in Thymidylate synthase gene as markers for response to 5-Fluorouracil based treatment regimen in Gastric Cancer in an Indian Population (awaiting sanction for funding ICMR).

Notable Cases Handled:
Dr. Jovita Martin Daniel has successfully managed numerous complex oncology cases, including those involving rare tumours and synchronous malignancies. Her research and publications reflect her commitment to advancing understanding and treatment in areas such as triple-negative breast cancer, granulosa cell tumours, and the challenges of cancer treatment during global pandemics.

Patient Testimonials:

• “Dr. Jovita Martin Daniel is an incredibly knowledgeable and compassionate doctor. She explained my breast cancer treatment plan in detail, alleviating all my fears. I truly felt cared for and supported throughout my journey. Highly recommend her as a top Medical Oncologist in Chennai.” - Priya S.
• “Finding a specialist who understood my specific gynaecological cancer was crucial. Dr. Jovita’s expertise and reassuring demeanour made all the difference. Her team was excellent, and the care I received was exceptional. She’s a leading oncologist who genuinely cares.” - Anusha R.
• “My family consulted Dr. Jovita for a complex case of lung cancer. Her approach was thorough, and she presented all possible options with clarity. We appreciated her dedication to finding the best treatment strategy. A truly dedicated and leading oncologist in India.” - Rajesh K.

Patient-Centred Care: Dr. Jovita M. Martin Daniel is dedicated to providing personalised, compassionate, and patient-centred care. She believes in empowering patients with comprehensive information about their condition and treatment options, ensuring they are active participants in their healthcare decisions. Her focus extends to palliative care, aiming to improve the quality of life for her patients throughout their treatment journey.

Technology & Innovation: Dr. Martin Daniel is at the forefront of oncology, integrating advanced medical technologies and innovative treatment modalities into her practice. Her interest in Precision Oncology, Targeted Therapy, and Immuno-Oncology reflects her commitment to utilising the latest scientific advancements for optimal patient outcomes. Her involvement in clinical trials ensures access to cutting-edge treatments.

Treatment costs can vary significantly depending on the specific cancer, the stage of the disease, the chosen treatment protocol (e.g., chemotherapy, targeted therapy, immunotherapy, radiation therapy), the duration of treatment, and any associated hospitalisation or supportive care.

Note: These are just estimates. Contact Cancer Rounds for a personalised quote.

Language Support: Cancer Rounds provides comprehensive support for international patients, including access to language interpreters to ensure clear communication during consultations and throughout the treatment process.

Visa & Travel Assistance: The Cancer Rounds team assists with visa applications, travel arrangements, airport transfers, and accommodation, ensuring a smooth and stress-free experience for patients travelling to Chennai for treatment.

Pre-treatment Virtual Consultations: To facilitate initial assessments and discussions, pre-treatment virtual consultations are available through Cancer Rounds, allowing international patients to receive expert opinions and treatment planning before their arrival.